Chemours (CC) PT Lowered to $62 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Chemours (CC) PT Lowered to $68 at BMO Capital
August 6, 2018 8:30 AM EDTBMO Capital lowered its price target on Chemours (NYSE: CC) to $68.00 (from $70.00) while maintaining a Outperform rating.
... MoreChemours (CC) PT Lowered to $47 at UBS
August 3, 2018 8:48 AM EDTUBS lowered its price target on Chemours (NYSE: CC) to $47.00 (from $50.00) while maintaining a Neutral rating.
... MoreChemours (CC) Tops Q2 EPS by 12c
August 2, 2018 4:38 PM EDTChemours (NYSE: CC) reported Q2 EPS of $1.71, $0.12 better than the analyst estimate of $1.59. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.82 billion.
For earnings history and earnings-related data on Chemours (CC) click here.
... More